Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 16;34(8):1041-1044.
doi: 10.1515/jpem-2020-0594. Print 2021 Aug 26.

Transient neonatal hyperinsulinism: early predictors of duration

Affiliations

Transient neonatal hyperinsulinism: early predictors of duration

Shai Fuchs et al. J Pediatr Endocrinol Metab. .

Abstract

Objectives: Hyperinsulinism is the most common cause of recurrent hypoglycemia in infants, with transient and permanent forms. Currently, there are no effective tools to predict severity and time to resolution in infants with transient hyperinsulinism (tHI). Therefore, our objective was to assess whether early glucose trends predict disease duration in tHI.

Methods: A retrospective, pilot cohort of infants admitted with tHI was phenotyped for clinical and laboratory parameters. Blood glucose (BG) values were collected from the first documented hypoglycemia for 120 h (five days).

Results: In 27 neonates with tHI, the presence of fetal distress (p=0.001) and higher mean daily BG (p=0.035) were associated with shorter time to resolution of hypoglycemia. In a further sensitivity analysis that grouped the cohort by the presence or absence of fetal distress, we found that in neonates without fetal distress, lower mean daily glucose was associated with longer disease duration (R2=0.53, p=0.01).

Conclusions: Our pilot data suggests that predictors for disease duration of tHI may be elicited in the first week of life, and that tHI associated with fetal distress may represent a distinct clinical entity with a shorter time course.

Keywords: disease duration; fetal distress; hyperinsulinism; neonates.

PubMed Disclaimer

References

    1. Shah, P, Rahman, SA, Demirbilek, H, Guemes, M, Hussain, K. Hyperinsulinaemic hypoglycaemia in children and adults. Lancet Diabetes Endocrinol 2017;5:729–42. https://doi.org/10.1016/s2213-8587(16)30323-0.
    1. Burns, CM, Rutherford, MA, Boardman, JP, Cowan, FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics 2008;122:65–74. https://doi.org/10.1542/peds.2007-2822.
    1. Menni, F, de Lonlay, P, Sevin, C, Touati, G, Peigne, C, Barbier, V, et al.. Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics 2001;107:476–9. https://doi.org/10.1542/peds.107.3.476.
    1. McKinlay, CJD, Alsweiler, JM, Anstice, NS, Burakevych, N, Chakraborty, A, Chase, JG, et al.. Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years. JAMA Pediatr 2017;171:972–83. https://doi.org/10.1001/jamapediatrics.2017.1579.
    1. Kostopoulou, E, Shah, P. Hyperinsulinaemic hypoglycaemia-an overview of a complex clinical condition. Eur J Pediatr 2019;178:1151–60. https://doi.org/10.1007/s00431-019-03414-8.

LinkOut - more resources